Basic Stock Data on Achillion Pharmaceuticals, Inc. (ACHN)

In the past 52-week period, shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) have moved within the range of $2.95 to $5.66. On the stock’s most recent trading day, the company’s shares ended the regular session at $3.43, which is 39.4% higher than its 52-week high.

Achillion Pharmaceuticals, Inc. (ACHN) has demonstrated a 20-day simple moving average (SMA) of -11.07%, and a 50-day SMA of -16.59%. This public company’s current market capitalization stands at $490.80 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

When considering entering a position, it is crucial to understand the average enthusiasm level expressed by Wall Street analysts for that particular stock. According to the latest data, the consensus recommendation for Achillion Pharmaceuticals, Inc. (ACHN) is Outperform.

Publicly-traded organizations typically post revenue and earnings results that fall either above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Achillion Pharmaceuticals, Inc. (ACHN) delivered a 0.00% surprise with its net revenue.

Ownership at Achillion Pharmaceuticals, Inc. (ACHN), According to Most Recent SEC Filings

We can find critical insight by examining institutional ownership, which are reported in public companies’ most recent 13F filings. Achillion Pharmaceuticals, Inc. (ACHN) has 0 billion shares outstanding currently, 80.97% of which belong to institutional investors. Those institutional holdings amount to $0.38 billion.

Additionally, according to the most recent 13F filing from Achillion Pharmaceuticals, Inc. (ACHN), there were 17 new positions totaling 5,781,440 shares of the company’s stock. There were 17 sold out positions, on the other hand, totaling 6,273,917 shares.

Short, Medium and Long Term Indicators

A stock’s average trade volume, as recorder over the short, medium and long terms, is helpful to analyze in order to gain a better understanding of trading activity and investor sentiment. Achillion Pharmaceuticals, Inc. (ACHN) has had a 20-day average volume of 2,310,825 shares, with an average of 80% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 1,961,866 shares, with an average of 100% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,849,079 shares with 100% of long-term indicators pointing to Sell.